Stock

Fortrea Holdings Inc. FTRE

$17.67-2.05%

All stocks Create account to unlock

Overview

FTRE market data

Price History

FTRE price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for FTRE. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

7 captured

Global Clinical Trials Market to Reach $176.32 Billion by 2030 as AI and Decentralized Research Accelerate Growth · Jul 15, 2026, 11:15 AM

8-K filing — Fortrea Holdings Inc. (FTRE) · Jul 14, 2026, 8:05 PM

Mizuho Maintains Neutral on Fortrea Holdings, Raises Price Target to $16 · Jul 13, 2026, 12:14 PM

Fortrea Reiterates FY26 Guidance, Targeting Revenues In Range Of $2.550B-$2.650B Vs $2.594B Est., And Adjusted EBITDA Of $190M-$220M · Jun 26, 2026, 11:15 AM

Fortrea Appoints Jason Knoblauch As CFO, Effective July 6, Succeeding Jill Mcconnell · Jun 26, 2026, 11:15 AM

Okta To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Wednesday · Jun 24, 2026, 1:00 PM

Fortrea to Attend Jefferies Global Healthcare Conference · Jun 2, 2026, 10:15 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock